An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Public ClinicalTrials.gov record NCT02761187. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Global, Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Patients - the INSIGHT - MM Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to describe contemporary, real-world patterns of participant characteristics, clinical disease presentation, therapeutic regimen chosen, and clinical outcomes in participants with newly diagnosed \[ND\] multiple myeloma (MM) and participants with relapsed/refractory \[R/R\] MM.
Study identification
- NCT ID
- NCT02761187
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 4,253 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 1, 2016 (Actual)
- Primary completion
- Sep 30, 2021 (Actual)
- Completion
- Sep 30, 2021 (Actual)
- Last update posted
- Feb 24, 2025
2016 – 2021
United States locations
- U.S. sites
- 43
- U.S. states
- 26
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CARTI Cancer Center | Little Rock | Arkansas | 72205 | — |
| University of Arkansas For Medical Sciences | Little Rock | Arkansas | 72205 | — |
| University of California San Diego | La Jolla | California | 92093 | — |
| St Joseph Heritage Healthcare | Santa Rosa | California | 95403 | — |
| Rocky Mountain Cancer Centers (Williams) - USOR | Denver | Colorado | 80218 | — |
| Poudre Valley Health System | Fort Collins | Colorado | 80528 | — |
| George Washington University | Washington D.C. | District of Columbia | 20037 | — |
| SCRI Florida Cancer Specialists East | Daytona Beach | Florida | 32117 | — |
| SCRI Florida Cancer Specialists South | Fort Myers | Florida | 33916 | — |
| SCRI Florida Cancer Specialists North | St. Petersburg | Florida | 33705 | — |
| Illinois Cancer Specialists (Niles) - USOR | Niles | Illinois | 60714 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| East Jefferson General Hospital | Metairie | Louisiana | 70006 | — |
| Central Maine Medical Center | Lewiston | Maine | 04240 | — |
| Maryland Oncology Hematology (Columbia) - USOR | Columbia | Maryland | 21044 | — |
| Barbara Ann Karmanos Cancer Center | Detroit | Michigan | 48201 | — |
| Park Nicollet Institute | Saint Louis Park | Minnesota | 55416 | — |
| Central Care Cancer Center | Bolivar | Missouri | 65613 | — |
| Kansas City VA Medical Center | Kansas City | Missouri | 64128 | — |
| Washington University in St. Louis | St Louis | Missouri | 63110 | — |
| Hunterdon Hematology Oncology | Flemington | New Jersey | 08822 | — |
| San Juan Oncology Associates | Farmington | New Mexico | 87401 | — |
| Saint Francis Hospital | East Hills | New York | 11576 | — |
| Mount Sinai Medical Center | New York | New York | 10029 | — |
| Levine Cancer Center | Charlotte | North Carolina | 28402 | — |
| University of Cincinnati | Cincinnati | Ohio | 45220 | — |
| Hematology Oncology Associates - USOR | Medford | Oregon | 97504 | — |
| Northwest Cancer Specialists (Broadway) - USOR | Portland | Oregon | 97227 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
| Veterans Affairs Pittsburgh Healthcare System | Pittsburgh | Pennsylvania | 15240 | — |
| Greenville Health System Cancer Institute | Greenville | South Carolina | 29615 | — |
| SCRI Tennessee Oncology Nashville | Nashville | Tennessee | 37203 | — |
| Texas Oncology (Loop) - USOR | Amarillo | Texas | 79106 | — |
| Texas Oncology (Loop) - USOR | Dallas | Texas | 92056 | — |
| Texas Oncology (Loop) - USOR | El Paso | Texas | 79902 | — |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Texas Oncology (Loop) - USOR | Round Rock | Texas | 78681 | — |
| Texas Oncology (Loop) - USOR | San Antonio | Texas | 78217 | — |
| Yakima Valley Memorial Hospital North Star Lodge - USOR | Yakima | Washington | 98902 | — |
| Berkeley Medical Center | Martinsburg | West Virginia | 25401 | — |
| St Vincent Hospital | Green Bay | Wisconsin | 54307 | — |
| University of Wisconsin Carbone Cancer Center | Madison | Wisconsin | 53792 | — |
| Aurora Health Care, Aurora Cancer Care | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 94 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02761187, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 24, 2025 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02761187 live on ClinicalTrials.gov.